Phi Optics, Inc., a Champaign, IL-based developer of imaging solutions for life sciences and bio-pharma researchers, raised $250k in seed funding.
The round was led by Serra Ventures with participation from Newport Holdings LP and Illinois Ventures LLC.
The company intends to use the funds to develop optical microscopes designed for sensitive imaging of live cells and tissues using its patented technology.
Founded by CEO Gabriel Popescu and Catalin Chiritescu, Phi Optics designs and manufactures devices based on Quantitative Phase Imaging (QPI), a label free and quantitative imaging technology with nanoscale sensitivity. QPI-enabled devices have applications in life sciences, diagnostic pathology, and nanotechnology markets.
The company, which also received a Phase 1 SBIR (Small Business Innovation Research) award from the National Science Foundation (NSF), is located in the EnterpriseWorks incubator in the University of Illinois Research Park.